Pura Vida Investments’s Cymabay Therapeutics CBAY Stock Holding History

Pura Vida Investments’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Hold	0	–	–	–	174
2020 Q1	–	Hold	0	–	–	–	166
2019 Q4	–	Hold	0	–	–	–	158
2019 Q3	–	Hold	0	–	–	–	160
2016 Q2	–	Sell	-56,000	Closed	-$76K	–	105
2016 Q1	$76K	Sell	56,000 -144,000	-72%	-$178K	0.05%	76
2015 Q4	$338K	Hold	200,000	–	–	0.22%	69
2015 Q3	$388K	Hold	200,000	–	–	0.26%	58
2015 Q2	$602K	Buy	+200,000	New	+$821K	0.36%	59

Other funds holding CBAY

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return